MEETINGS - Conference on Clarifying Adverse Event Reporting Responsibilities for Medical Devices and Borderline Products (UK) March 2000:
This article was originally published in Clinica
Executive Summary
IIR will hold a conference on Clarifying Adverse Event Reporting Responsibilities for Medical Devices and Borderline Products in London on March 27-28. The meeting will include a keynote address from Joseph Putzeys of the European Commission on implementation of the medical device directives in Europe. There will also be regulatory updates from the UK, France, Germany, Hungary and Norway and practical industry case studies on successfully managing adverse event reporting for medical devices. IIR will also hold a workshop on Overcoming the Practical Challenges of Product Labelling for Medical Devices in London on March 29. For more information contact IIR in UK. Tel: +44 20 7915 5055. Fax: +44 171 915 5001.
You may also be interested in...
Japan Grants Global-First Approval To Zolbetuximab, 15 Other New Drugs
Astellas's first-in class CLDN18.2-targeting antibody receives its first approval worldwide, while crovalimab and a number of drugs for rare diseases also receive nods from regulators and are now awaiting reimbursement price-listing.
Hanmi-OCI Merger Hits Wall As Brothers Win Shareholder Vote, Board Seats
The planned merger of Korea's Hanmi Pharm Group with OCI Group hits a major speed bump as the two sons of Hanmi's founder and other candidates recommended by them secture board seats. But it remains to be seen how the Lim brothers will fulfil their ambitious promises.
Beauty Firms Using AI-Based Tools Could Be Subject To Health Privacy Laws In US States
Using AI-based programs to collect and store consumer information risks running afoul of new health privacy laws cropping up in US states. Lack of federal regulation or guidance on the issue is one of the biggest challenges for beauty firms deploying AI, according to Stacy Marcus, partner at Reed Smith LLP.